PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis

被引:33
作者
Sabatino, Lina [1 ]
Fucci, Alessandra [1 ]
Pancione, Massimo [1 ]
Colantuoni, Vittorio [1 ]
机构
[1] Univ Sannio, Dept Biol Geol & Environm Sci, I-82100 Benevento, Italy
关键词
PROLIFERATOR-ACTIVATED-RECEPTOR; INTESTINAL POLYP FORMATION; GAMMA LIGAND TROGLITAZONE; ABERRANT CRYPT FOCI; DE-NOVO METHYLATION; HUMAN BREAST-CANCER; LONG NONCODING RNA; DNA METHYLATION; COLON-CANCER; CELL-GROWTH;
D O I
10.1155/2012/687492
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Peroxisome proliferator-activated receptor gamma (PPAR gamma) plays critical roles in lipid storage, glucose metabolism, energy homeostasis, adipocyte differentiation, inflammation, and cancer. Its function in colon carcinogenesis has largely been debated; accumulating evidence, however, supports a role as tumor suppressor through modulation of crucial pathways in cell differentiation, apoptosis, and metastatic dissemination. Epigenetics adds a further layer of complexity to gene regulation in several biological processes. In cancer, the relationship with epigenetic modifications has provided important insights into the underlying molecular mechanisms. These studies have highlighted how epigenetic modifications influence PPARG gene expression in colorectal tumorigenesis. In this paper, we take a comprehensive look at the current understanding of the relationship between PPAR gamma and cancer development. The role that epigenetic mechanisms play is also addressed disclosing novel crosstalks between PPARG signaling and the epigenetic machinery and suggesting how this dysregulation may contribute to colon cancer development.
引用
收藏
页数:12
相关论文
共 143 条
  • [1] A single-base mutation in the peroxisome proliferator-activated receptor γ4 promoter associated with altered in vitro expression and partial lipodystrophy
    Al-Shali, K
    Cao, HN
    Knoers, N
    Hermus, AR
    Tack, CJ
    Hegele, RA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11) : 5655 - 5660
  • [2] Smoldering and polarized inflammation in the initiation and promotion of malignant disease
    Balkwill, F
    Charles, KA
    Mantovani, A
    [J]. CANCER CELL, 2005, 7 (03) : 211 - 217
  • [3] Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
    Berdasco, Maria
    Esteller, Manel
    [J]. DEVELOPMENTAL CELL, 2010, 19 (05) : 698 - 711
  • [4] MAPK kinases as nucleo-cytoplasmic shuttles for PPARγ
    Burgermeister, Elke
    Seger, Rony
    [J]. CELL CYCLE, 2007, 6 (13) : 1539 - 1548
  • [5] Use of the peroxisome proliferator-activated receptor (PPAR) γ ligand troglitazone as treatment for refractory breast cancer:: a phase II study
    Burstein, HJ
    Demetri, GD
    Mueller, E
    Sarraf, P
    Spiegelman, BM
    Winer, EP
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 (03) : 391 - 397
  • [6] Functional genomic analysis reveals cross-talk between peroxisome proliferator-activated receptor γ and calcium signaling in human colorectal cancer cells
    Bush, Craig R.
    Havens, Jennifer M.
    Necela, Brian M.
    Su, Weidong
    Chen, Lu
    Yanagisawa, Masahiro
    Anastasiadis, Panos Z.
    Guerra, Rudy
    Luxon, Bruce A.
    Thompson, E. Aubrey
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (32) : 23387 - 23401
  • [7] Epigenomics of human colon cancer
    Carmona, F. Javier
    Esteller, Manel
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2010, 693 (1-2) : 53 - 60
  • [8] In vivo effects of rosiglitazone in a human neuroblastoma xenograft
    Cellai, I.
    Petrangolini, G.
    Tortoreto, M.
    Pratesi, G.
    Luciani, P.
    Deledda, C.
    Benvenuti, S.
    Ricordati, C.
    Gelmini, S.
    Ceni, E.
    Galli, A.
    Balzi, M.
    Faraoni, P.
    Serio, M.
    Peri, A.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (04) : 685 - 692
  • [9] Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and Nf-kB in human colon cancer
    Chen, GG
    Lee, JFY
    Wang, SH
    Chan, UPF
    Ip, PC
    Lau, WY
    [J]. LIFE SCIENCES, 2002, 70 (22) : 2631 - 2646
  • [10] Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1
    Copland, JA
    Marlow, LA
    Kurakata, S
    Fujiwara, K
    Wong, AKC
    Kreinest, PA
    Williams, SF
    Haugen, BR
    Klopper, JP
    Smallridge, RC
    [J]. ONCOGENE, 2006, 25 (16) : 2304 - 2317